Skip to main content
SpringerLink
Log in

Liposome protein corona characterization as a new approach in nanomedicine

  • Trends
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

This trends article describes the analytical approaches for the in-depth characterization of the protein corona on liposome nanoparticles. In particular, examples since 2014 are summarized according to the analytical approach. Traditional protein corona characterizations from in vitro static experiments are provided along with the newly introduced experimental setups for characterization of the protein corona by in vitro dynamic and in vivo studies. Additionally, a special attention is also devoted to the need for introduction of new experimental workflows for characterization of a much wider array of biomolecules. In the most recent years, an extension of the protein corona concept to the biomolecular corona was introduced, and the analytical targets are no longer restricted to proteins, but to other important biomolecules as well, as they can potentially affect the biodistribution and interaction of nanoparticles with the biological systems. The few recent examples in this field are discussed for the characterization of metabolites and lipids in the biomolecular corona with examples, also extending the discussion from liposome to other types of nanoparticles. A final discussion is provided on the potential key role of the most recent omics approaches in the study of the nano-bio interface, with an overview on top-down proteomics, which allows a better elucidation of proteoforms, and on lipidomics and metabolomics, which allow a comprehensive untargeted characterization of lipids and metabolites, respectively.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yang J, Bahreman A, Daudey G, Bussmann J, Olsthoorn RCL, Kros A. Drug delivery via cell membrane fusion using lipopeptide modified liposomes. ACS Cent Sci. 2016;2:621–30. https://doi.org/10.1021/acscentsci.6b00172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed. 2007;46:5754–6. https://doi.org/10.1002/anie.200700465.

    Article  CAS  Google Scholar 

  3. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci. 2008;105:14265–70. https://doi.org/10.1073/pnas.0805135105.

    Article  PubMed  Google Scholar 

  4. Monopoli MP, Bombelli FB, Dawson KA. Nanoparticle coronas take shape. Nat Nanotechnol. 2011;6:11–2. https://doi.org/10.1038/nnano.2011.267.

    Article  CAS  PubMed  Google Scholar 

  5. Capriotti AL, Caracciolo G, Cavaliere C, Foglia P, Pozzi D, Samperi R, et al. Do plasma proteins distinguish between liposomes of varying charge density? J Proteome. 2012;75:1924–32. https://doi.org/10.1016/j.jprot.2012.01.003.

    Article  CAS  Google Scholar 

  6. Caracciolo G, Pozzi D, Capriotti AL, Marianecci C, Carafa M, Marchini C, et al. Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes. J Med Chem. 2011;54:4160–71. https://doi.org/10.1021/jm200237p.

    Article  CAS  PubMed  Google Scholar 

  7. Caracciolo G. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. Nanomedicine. 2015;11:543–57. https://doi.org/10.1016/j.nano.2014.11.003.

    Article  CAS  PubMed  Google Scholar 

  8. Docter D, Westmeier D, Markiewicz M, Stolte S, Knauer SK, Stauber RH. The nanoparticle biomolecule corona: lessons learned—challenge accepted? Chem Soc Rev. 2015;44:6094–121. https://doi.org/10.1039/c5cs00217f.

    Article  CAS  PubMed  Google Scholar 

  9. Tavano R, Gabrielli L, Lubian E, Fedeli C, Visentin S, Polverino De Laureto P, et al. C1q-mediated complement activation and C3 opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes. ACS Nano. 2018;12:5834–47. https://doi.org/10.1021/acsnano.8b01806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Caracciolo G, Farokhzad OC, Mahmoudi M. Biological identity of nanoparticles in vivo: clinical implications of the protein corona. Trends Biotechnol. 2017;35:257–64. https://doi.org/10.1016/j.tibtech.2016.08.011.

    Article  CAS  PubMed  Google Scholar 

  11. Salvati A, Pitek AS, Monopoli MP, Prapainop K, Bombelli FB, Hristov DR, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8:137–43. https://doi.org/10.1038/nnano.2012.237.

    Article  CAS  PubMed  Google Scholar 

  12. Zarschler K, Prapainop K, Mahon E, Rocks L, Bramini M, Kelly PM, et al. Diagnostic nanoparticle targeting of the EGF-receptor in complex biological conditions using single-domain antibodies. Nanoscale. 2014;6:6046–56. https://doi.org/10.1039/c4nr00595c.

    Article  CAS  PubMed  Google Scholar 

  13. Tonigold M, Simon J, Estupiñán D, Kokkinopoulou M, Reinholz J, Kintzel U, et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. Nat Nanotechnol. 2018;13:862–9. https://doi.org/10.1038/s41565-018-0171-6.

    Article  CAS  PubMed  Google Scholar 

  14. Kelly PM, Åberg C, Polo E, O’Connell A, Cookman J, Fallon J, et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. Nat Nanotechnol. 2015;10:472–9. https://doi.org/10.1038/nnano.2015.47.

    Article  CAS  PubMed  Google Scholar 

  15. Castagnola V, Zhao W, Boselli L, Lo Giudice MC, Meder F, Polo E, et al. Biological recognition of graphene nanoflakes. Nat Commun. 2018;9:1577. https://doi.org/10.1038/s41467-018-04009-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Herda LM, Hristov DR, Lo GMC, Polo E, Dawson KA. Mapping of molecular structure of the nanoscale surface in bionanoparticles. J Am Chem Soc. 2017;139:111–4. https://doi.org/10.1021/jacs.6bl2297.

    Article  CAS  PubMed  Google Scholar 

  17. Pozzi D, Colapicchioni V, Caracciolo G, Piovesana S, Capriotti AL, Palchetti S, et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale. 2014;6:2782–92. https://doi.org/10.1039/c3nr05559k.

    Article  CAS  PubMed  Google Scholar 

  18. Xiao W, Gao H. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int J Pharm. 2018;552:328–39. https://doi.org/10.1016/j.ijpharm.2018.10.011.

    Article  CAS  PubMed  Google Scholar 

  19. Carrillo-Carrion C, Carril M, Parak WJ. Techniques for the experimental investigation of the protein corona. Curr Opin Biotechnol. 2017;46:106–13. https://doi.org/10.1016/j.copbio.2017.02.009.

    Article  CAS  PubMed  Google Scholar 

  20. Capriotti AL, Caracciolo G, Caruso G, Cavaliere C, Pozzi D, Samperi R, et al. Analysis of plasma protein adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal Bioanal Chem. 2010;398:2895–903. https://doi.org/10.1007/s00216-010-4104-y.

    Article  CAS  PubMed  Google Scholar 

  21. Capriotti AL, Caracciolo G, Cavaliere C, Colapicchioni V, Piovesana S, Pozzi D, et al. Analytical methods for characterizing the nanoparticle-protein corona. Chromatographia. 2014;77:755–69.

    Article  CAS  Google Scholar 

  22. Benne N, van Duijn J, Lozano Vigario F, Leboux RJT, van Veelen P, Kuiper J, et al. Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice. J Control Release. 2018;291:135–46. https://doi.org/10.1016/j.jconrel.2018.10.028.

    Article  CAS  PubMed  Google Scholar 

  23. Guan J, Shen Q, Zhang Z, Jiang Z, Yang Y, Lou M, et al. Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption. Nat Commun. 2018;9:2982. https://doi.org/10.1038/s41467-018-05384-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Caracciolo G, Palchetti S, Digiacomo L, Chiozzi RZZ, Capriotti AL, Amenitsch H, et al. Human biomolecular corona of liposomal doxorubicin: the overlooked factor in anticancer drug delivery. ACS Appl Mater Interfaces. 2018;10:22951–62. https://doi.org/10.1021/acsami.8b04962.

    Article  CAS  PubMed  Google Scholar 

  25. Arcella A, Palchetti S, Digiacomo L, Pozzi D, Capriotti AL, Frati L, et al. Brain targeting by liposome-biomolecular corona boosts anti-cancer efficacy of temozolomide in glioblastoma cells. ACS Chem Neurosci. 2018. https://doi.org/10.1021/acschemneuro.8b00339.

  26. Al-Ahmady ZS, Hadjidemetriou M, Gubbins J, Kostarelos K. Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes. J Control Release. 2018;276:157–67. https://doi.org/10.1016/j.jconrel.2018.02.038.

    Article  CAS  PubMed  Google Scholar 

  27. Palchetti S, Pozzi D, Capriotti AL, La Barbera G, Chiozzi RZ, Digiacomo L, et al. Influence of dynamic flow environment on nanoparticle-protein corona: from protein patterns to uptake in cancer cells. Colloids Surfaces B Biointerfaces. 2017;153:263–71. https://doi.org/10.1016/j.colsurfb.2017.02.037.

    Article  CAS  PubMed  Google Scholar 

  28. Papi M, Caputo D, Palmieri V, Coppola R, Palchetti S, Bugli F, et al. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. Nanoscale. 2017;9:10327–34. https://doi.org/10.1039/c7nr03042h.

    Article  CAS  PubMed  Google Scholar 

  29. Tretiakova DS, Onishchenko NR, Vostrova AG, Vodovozova EL. Interactions of liposomes carrying lipophilic prodrugs in the bilayer with blood plasma proteins. Russ J Bioorg Chem. 2017;43:678–89. https://doi.org/10.1134/S1068162017060139.

    Article  CAS  Google Scholar 

  30. Digiacomo L, Cardarelli F, Pozzi D, Palchetti S, Digman MA, Gratton E, et al. An apolipoprotein-enriched biomolecular corona switches the cellular uptake mechanism and trafficking pathway of lipid nanoparticles. Nanoscale. 2017;9:17254–62. https://doi.org/10.1039/c7nr06437c.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Itoh N, Kimoto A, Yamamoto E, Higashi T, Santa T, Funatsu T, et al. High performance liquid chromatography analysis of 100-nm liposomal nanoparticles using polymer-coated, silica monolithic columns with aqueous mobile phase. J Chromatogr A. 2017;1484:34–40. https://doi.org/10.1016/j.chroma.2016.12.080.

    Article  CAS  PubMed  Google Scholar 

  32. Corbo C, Molinaro R, Taraballi F, Toledano Furman NE, Hartman KA, Sherman MB, et al. Unveiling the in vivo protein corona of circulating leukocyte-like carriers. ACS Nano. 2017;11:3262–73. https://doi.org/10.1021/acsnano.7b00376.

    Article  CAS  PubMed  Google Scholar 

  33. Hadjidemetriou M, Al-Ahmady Z, Kostarelos K. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. Nanoscale. 2016;8:6948–57. https://doi.org/10.1039/c5nr09158f.

    Article  CAS  PubMed  Google Scholar 

  34. Corbo C, Molinaro R, Taraballi F, Toledano Furman NE, Sherman MB, Parodi A, et al. Effects of the protein corona on liposome-liposome and liposome-cell interactions. Int J Nanomedicine. 2016;11:3049–63. https://doi.org/10.2147/IJN.S109059.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Amici A, Caracciolo G, Digiacomo L, Gambini V, Marchini C, Tilio M, et al. In vivo protein corona patterns of lipid nanoparticles. RSC Adv. 2017;7:1137–45. https://doi.org/10.1039/c6ra25493d.

    Article  CAS  Google Scholar 

  36. Bigdeli A, Palchetti S, Pozzi D, Hormozi-Nezhad MR, Baldelli Bombelli F, Caracciolo G, et al. Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties. ACS Nano. 2016;10:3723–37. https://doi.org/10.1021/acsnano.6b00261.

    Article  CAS  PubMed  Google Scholar 

  37. Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Piovesana S, La Barbera G, et al. The liposome-protein corona in mice and humans and its implications for in vivo delivery. J Mater Chem B. 2014;2:7419–28. https://doi.org/10.1039/c4tb01316f.

    Article  CAS  Google Scholar 

  38. Pozzi D, Caracciolo G, Digiacomo L, Colapicchioni V, Palchetti S, Capriotti AL, et al. The biomolecular corona of nanoparticles in circulating biological media. Nanoscale. 2015;7:13958–66. https://doi.org/10.1039/c5nr03701h.

    Article  CAS  PubMed  Google Scholar 

  39. Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Piovesana S, Amenitsch H, et al. Lipid composition: a “key factor” for the rational manipulation of the liposome-protein corona by liposome design. RSC Adv. 2015;5:5967–75. https://doi.org/10.1039/c4ra13335h.

    Article  CAS  Google Scholar 

  40. Pozzi D, Caracciolo G, Capriotti AL, Cavaliere C, La Barbera G, Anchordoquy TJ, et al. Surface chemistry and serum type both determine the nanoparticle-protein corona. J Proteome. 2015;119:209–17. https://doi.org/10.1016/j.jprot.2015.02.009.

    Article  CAS  Google Scholar 

  41. Hadjidemetriou M, Al-Ahmady Z, Mazza M, Collins RF, Dawson K, Kostarelos K. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano. 2015;9:8142–56. https://doi.org/10.1021/acsnano.5b03300.

    Article  CAS  PubMed  Google Scholar 

  42. Palchetti S, Colapicchioni V, Digiacomo L, Caracciolo G, Pozzi D, Capriotti AL, et al. The protein corona of circulating PEGylated liposomes. Biochim Biophys Acta Biomembr. 2016;1858:189–96. https://doi.org/10.1016/j.bbamem.2015.11.012.

    Article  CAS  Google Scholar 

  43. Mahmoudi M. Debugging nano–bio interfaces: systematic strategies to accelerate clinical translation of nanotechnologies. Trends Biotechnol. 2018;36:755–69. https://doi.org/10.1016/j.tibtech.2018.02.014.

    Article  CAS  PubMed  Google Scholar 

  44. Wang M, Gustafsson OJR, Pilkington EH, Kakinen A, Javed I, Faridi A, et al. Nanoparticle–proteome in vitro and in vivo. J Mater Chem B. 2018;6:6026–41. https://doi.org/10.1039/C8TB01634H.

    Article  CAS  Google Scholar 

  45. Papi M, Caracciolo G. Principal component analysis of personalized biomolecular corona data for early disease detection. Nano Today. 2018;21:14–7. https://doi.org/10.1016/j.nantod.2018.03.001.

    Article  CAS  Google Scholar 

  46. Hadjidemetriou M, Kostarelos K. Nanomedicine: evolution of the nanoparticle corona. Nat Nanotechnol. 2017;12:288–90. https://doi.org/10.1038/nnano.2017.61.

    Article  CAS  PubMed  Google Scholar 

  47. Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlbäck B, Dawson KA, et al. Complete high-density lipoproteins in nanoparticle corona. FEBS J. 2009;276:3372–81. https://doi.org/10.1111/j.1742-4658.2009.07062.x.

    Article  CAS  PubMed  Google Scholar 

  48. Müller J, Prozeller D, Ghazaryan A, Kokkinopoulou M, Mailänder V, Morsbach S, et al. Beyond the protein corona—lipids matter for biological response of nanocarriers. Acta Biomater. 2018;71:420–31. https://doi.org/10.1016/j.actbio.2018.02.036.

    Article  CAS  PubMed  Google Scholar 

  49. Raesch SS, Tenzer S, Storck W, Rurainski A, Selzer D, Ruge CA, et al. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano. 2015;9:11872–85. https://doi.org/10.1021/acsnano.5b04215.

    Article  CAS  PubMed  Google Scholar 

  50. Lee JY, Wang H, Pyrgiotakis G, DeLoid GM, Zhang Z, Beltran-Huarac J, et al. Analysis of lipid adsorption on nanoparticles by nanoflow liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2018;410:6155–64. https://doi.org/10.1007/s00216-018-1145-0.

    Article  CAS  PubMed  Google Scholar 

  51. Martel J, Wu CY, Hung CY, Wong TY, Cheng AJ, Cheng ML, et al. Fatty acids and small organic compounds bind to mineralo-organic nanoparticles derived from human body fluids as revealed by metabolomic analysis. Nanoscale. 2016;8:5537–45. https://doi.org/10.1039/c5nr08116e.

    Article  CAS  PubMed  Google Scholar 

  52. Pink M, Verma N, Kersch C, Schmitz-Spanke S. Identification and characterization of small organic compounds within the corona formed around engineered nanoparticles. Environ Sci Nano. 2018;5:1420–7. https://doi.org/10.1039/c8en00161h.

    Article  CAS  Google Scholar 

  53. Shannahan J. The biocorona: a challenge for the biomedical application of nanoparticles. Nanotechnol Rev. 2017;6:345–53. https://doi.org/10.1515/ntrev-2016-0098.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Tavakol M, Montazeri A, Naghdabadi R, Hajipour MJ, Zanganeh S, Caracciolo G, et al. Disease-related metabolites affect protein-nanoparticle interactions. Nanoscale. 2018;10:7108–15. https://doi.org/10.1039/c7nr09502c.

    Article  CAS  PubMed  Google Scholar 

  55. Riley NM, Sikora JW, Seckler HS, Greer JB, Fellers RT, Leduc RD, et al. The value of activated ion electron transfer dissociation for high-throughput top-down characterization of intact proteins. Anal Chem. 2018;90:8553–60. https://doi.org/10.1021/acs.analchem.8b01638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Smith LM, Kelleher NL. Proteoforms as the next proteomics currency. Science. 2018;359:1106–7. https://doi.org/10.1126/science.aat1884.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Schaffer LV, Rensvold JW, Shortreed MR, Cesnik AJ, Jochem A, Scalf M, et al. Identification and quantification of murine mitochondrial proteoforms using an integrated top-down and intact-mass strategy. J Proteome Res. 2018;17:3526–36. https://doi.org/10.1021/acs.jproteome.8b00469.

    Article  CAS  PubMed  Google Scholar 

  58. Cai W, Tucholski T, Chen B, Alpert AJ, McIlwain S, Kohmoto T, et al. Top-down proteomics of large proteins up to 223 kDa enabled by serial size exclusion chromatography strategy. Anal Chem. 2017;89:5467–75. https://doi.org/10.1021/acs.analchem.7b00380.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Wan S, Kelly PM, Mahon E, Stöckmann H, Rudd PM, Caruso F, et al. The “sweet” side of the protein corona: effects of glycosylation on nanoparticle-cell interactions. ACS Nano. 2015;9:2157–66. https://doi.org/10.1021/nn506060q.

    Article  CAS  PubMed  Google Scholar 

  60. McCool EN, Lubeckyj RA, Shen X, Chen D, Kou Q, Liu X, et al. Deep top-down proteomics using capillary zone electrophoresis-tandem mass spectrometry: identification of 5700 proteoforms from the Escherichia coli proteome. Anal Chem. 2018;90:5529–33. https://doi.org/10.1021/acs.analchem.8b00693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Kim YI, Cho JY. Gel-based proteomics in disease research: is it still valuable? Biochim Biophys Acta Proteins Proteomics. 2019;1867:9–16.

    Article  CAS  PubMed  Google Scholar 

  62. Cui L, Lu H, Lee YH. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases. Mass Spectrom Rev. 2018;37:772–92. https://doi.org/10.1002/mas.21562.

    Article  CAS  PubMed  Google Scholar 

  63. Rustam YH, Reid GE. Analytical challenges and recent advances in mass spectrometry based lipidomics. Anal Chem. 2018;90:374–97. https://doi.org/10.1021/acs.analchem.7b04836.

    Article  CAS  PubMed  Google Scholar 

  64. La Barbera G, Antonelli M, Cavaliere C, Cruciani G, Goracci L, Montone CM, et al. Delving into the polar lipidome by optimized chromatographic separation, high-resolution mass spectrometry, and comprehensive identification with Lipostar: microalgae as case study. Anal Chem. 2018;90:12230–8. https://doi.org/10.1021/acs.analchem.8b03482.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185, Rome, Italy

    Anna Laura Capriotti, Chiara Cavaliere & Susy Piovesana

Authors
  1. Anna Laura Capriotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Cavaliere
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susy Piovesana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susy Piovesana.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Published in the topical collection Young Investigators in (Bio-)Analytical Chemistry with guest editors Erin Baker, Kerstin Leopold, Francesco Ricci, and Wei Wang.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Capriotti, A.L., Cavaliere, C. & Piovesana, S. Liposome protein corona characterization as a new approach in nanomedicine. Anal Bioanal Chem 411, 4313–4326 (2019). https://doi.org/10.1007/s00216-019-01656-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-019-01656-x

Keywords

Search

Navigation